Cargando…
OSU-A9 inhibits pancreatic cancer cell lines by modulating p38-JAK-STAT3 signaling
Pancreatic cancer is an aggressive malignancy that is the fourth leading cause of death worldwide. Since there is a dire need for novel and effective therapies to improve the poor survival rates of advanced pancreatic cancer patients, we analyzed the antitumor effects of OSU-A9, an indole-3-carbinol...
Autores principales: | Tsai, Wan-Chi, Bai, Li-Yuan, Chen, Yi-Jin, Chu, Po-Chen, Hsu, Ya-Wen, Sargeant, Aaron M., Weng, Jing-Ru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5438726/ https://www.ncbi.nlm.nih.gov/pubmed/28418923 http://dx.doi.org/10.18632/oncotarget.16450 |
Ejemplares similares
-
Draft genome sequence of Lactobacillus helveticus OSU-BDGOAK2 and Lactobacillus kefiranofaciens OSU-BDGOA1, kefir grain isolates with potential antibacterial activity
por: González-Orozco, Brianda D., et al.
Publicado: (2023) -
1899. The Cellular Kinase Inhibitor OSU-03012 Inhibits Enterovirus 71 In Vitro
por: Chan, Jasper, et al.
Publicado: (2018) -
Comparison of 16 mm OSU‐Nag and COMS eye plaques
por: Zhang, Hualin, et al.
Publicado: (2012) -
JAK-STAT and intestinal mucosal immunology
por: Heneghan, Aaron F, et al.
Publicado: (2013) -
Re-Assembly of the Genome of Francisella tularensis Subsp. holarctica OSU18
por: Puiu, Daniela, et al.
Publicado: (2008)